# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015599
Filing Date
2018-11-13
Accepted
2018-11-09 18:30:36
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm | 10-Q | 730901
2 |  | ex31-1.htm | EX-31.1 | 13544
3 |  | ex32-1.htm | EX-32.1 | 5947
| Complete submission text file | 0001493152-18-015599.txt |  | 4903162

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL INSTANCE FILE | ppcb-20180930.xml | EX-101.INS | 720181
5 | XBRL SCHEMA FILE | ppcb-20180930.xsd | EX-101.SCH | 87566
6 | XBRL CALCULATION FILE | ppcb-20180930_cal.xml | EX-101.CAL | 48917
7 | XBRL DEFINITION FILE | ppcb-20180930_def.xml | EX-101.DEF | 215017
8 | XBRL LABEL FILE | ppcb-20180930_lab.xml | EX-101.LAB | 450532
9 | XBRL PRESENTATION FILE | ppcb-20180930_pre.xml | EX-101.PRE | 271850

Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 181174375
SIC: 2834 Pharmaceutical Preparations